+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Epidemic"

From
From
From
From
Collaboration Deals in Biotechnology 2019-2025 - Product Thumbnail Image

Collaboration Deals in Biotechnology 2019-2025

  • Report
  • April 2025
  • 1000 Pages
  • Global
From
From
From
From
Licensing Deals in Biotechnology 2019-2025 - Product Thumbnail Image

Licensing Deals in Biotechnology 2019-2025

  • Report
  • April 2025
  • 1250 Pages
  • Global
From
From
From
From
From
Diabetes Diagnostics - Global Strategic Business Report - Product Thumbnail Image

Diabetes Diagnostics - Global Strategic Business Report

  • Report
  • April 2025
  • 609 Pages
  • Global
From
Loading Indicator

The Epidemic market within the context of Biotechnology is a sector of the industry that focuses on the development of products and services to address the challenges posed by the spread of infectious diseases. This includes the development of vaccines, diagnostics, treatments, and other preventive measures. It also includes the development of technologies to monitor and track the spread of disease, as well as the development of public health policies and strategies to reduce the impact of epidemics. The Epidemic market is a rapidly growing sector of the biotechnology industry, with many companies investing in research and development to create new products and services. Companies in this market include Gilead Sciences, Moderna, Johnson & Johnson, Novavax, Inovio Pharmaceuticals, and Regeneron Pharmaceuticals. Show Less Read more